APA Zitierstil

Bays, H. E., Brinton, E. A., Triscari, J., Chen, E., Maccubbin, D., MacLean, A. A., . . . Mitchel, Y. B. (2015). Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control. Vasc Health Risk Manag.

Chicago Zitierstil

Bays, Harold E., et al. "Extended-release Niacin/laropiprant Significantly Improves Lipid Levels in Type 2 Diabetes Mellitus Irrespective of Baseline Glycemic Control." Vasc Health Risk Manag 2015.

MLA Zitierstil

Bays, Harold E., et al. "Extended-release Niacin/laropiprant Significantly Improves Lipid Levels in Type 2 Diabetes Mellitus Irrespective of Baseline Glycemic Control." Vasc Health Risk Manag 2015.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.